PIA
BIIB icon

Piedmont Investment Advisors’s Biogen BIIB Stock Holding History

Piedmont Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-30,034
Closed -$9.5M – 80
2020
Q1 		$9.5M Sell
30,034
-10,568
-26% -$3.21M 0.38% 60
2019
Q4 		$12M Buy
40,602
+13,210
+48% +$3.67M 0.42% 54
2019
Q3 		$6.38M Buy
27,392
+12,580
+85% +$2.93M 0.25% 102
2019
Q2 		$3.46M Sell
14,812
-8,951
-38% -$2.07M 0.14% 157
2019
Q1 		$5.62M Buy
23,763
+6,966
+41% +$2.19M 0.23% 113
2018
Q4 		$5.05M Buy
16,797
+952
+6% +$304K 0.24% 101
2018
Q3 		$5.6M Buy
15,845
+6,763
+74% +$2.33M 0.24% 102
2018
Q2 		$2.64M Sell
9,082
-41,308
-82% -$11.6M 0.13% 167
2018
Q1 		$13.8M Sell
50,390
-13,693
-21% -$4.25M 0.37% 64
2017
Q4 		$20.4M Buy
64,083
+18,327
+40% +$5.88M 0.41% 57
2017
Q3 		$14.3M Buy
45,756
+414
+0.9% +$123K 0.3% 86
2017
Q2 		$12.3M Sell
45,342
-1,110
-2% -$294K 0.27% 101
2017
Q1 		$12.7M Buy
46,452
+399
+0.9% +$113K 0.26% 107
2016
Q4 		$13.1M Buy
46,053
+988
+2% +$293K 0.27% 103
2016
Q3 		$14.1M Sell
45,065
-14,473
-24% -$4.29M 0.31% 86
2016
Q2 		$14.4M Sell
59,538
-72,199
-55% -$19M 0.3% 89
2016
Q1 		$34.3M Sell
131,737
-2,107
-2% -$557K 0.72% 46
2015
Q4 		$41M Buy
133,844
+18,084
+16% +$5.2M 0.87% 34
2015
Q3 		$33.8M Buy
115,760
+15,163
+15% +$5.01M 0.76% 41
2015
Q2 		$40.6M Buy
100,597
+41,377
+70% +$16.6M 0.86% 27
2015
Q1 		$25M Sell
59,220
-5,218
-8% -$2.06M 1.53% 31
2014
Q4 		$21.9M Sell
64,438
-47,614
-42% -$15.4M 1.32% 35
2014
Q3 		$37.1M Buy
112,052
+10,146
+10% +$3.35M 1.92% 23
2014
Q2 		$32.1M Sell
101,906
-19,114
-16% -$5.75M 1.68% 25
2014
Q1 		$37M Sell
121,020
-27,808
-19% -$8.83M 2.03% 16
2013
Q4 		$41.6M Buy
148,828
+85,834
+136% +$22.2M 2.23% 14
2013
Q3 		$15.2M Buy
62,994
+62,872
+51,534% +$14.1M 0.79% 42
2013
Q2 		$26.3K Buy
+122
New +$26.1K ﹤0.01% 234

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Piedmont Investment Advisors's BIIB Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Biogen (BIIB) in Q2 2020, closing a stake of 30,034 shares — an estimated $9.5M sold.

Piedmont Investment Advisors first reported a position in BIIB in Q2 2013 and held it in 28 quarters. The position peaked at $41.6M in Q4 2013. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 30,034 Biogen shares in Q2 2020, an estimated $9.5M.
  • Piedmont Investment Advisors first reported a position in Biogen in Q2 2013 and held it in 28 quarters.
  • Piedmont Investment Advisors's Biogen position peaked at $41.6M in Q4 2013.
  • 1,059 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.